Implications of fleroxacin's pharmacokinetic profile
- 31 July 1994
- journal article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 4, S7-S13
- https://doi.org/10.1016/0924-8579(94)90016-7
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Effect of sucralfate on pharmacokinetics of fleroxacin in healthy volunteersAntimicrobial Agents and Chemotherapy, 1992
- Penetration of fleroxacin and ciprofloxacin into skin blister fluid: a comparative studyAntimicrobial Agents and Chemotherapy, 1992
- The Relative Bioavailability of Temafloxacin Administered through a Nasogastric Tube With and Without Enteral FeedingClinical Pharmacokinetics, 1992
- Bioavailability and pharmacokinetics of ofloxacin in healthy volunteersAntimicrobial Agents and Chemotherapy, 1991
- Sucralfate significantly reduces ciprofloxacin concentrations in serumAntimicrobial Agents and Chemotherapy, 1990
- Absorption of ciprofloxacin administered through a nasogastric or a nasoduodenal tube in volunteers and patients receiving enteral nutritionDiagnostic Microbiology and Infectious Disease, 1990
- The Effect of Sucralfate Pretreatment on the Pharmacokinetics of CiprofloxacinPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1989
- Relative bioavailability in healthy volunteers of ciprofloxacin administered through a nasogastric tube with and without enteral feedingAntimicrobial Agents and Chemotherapy, 1989
- Sucralfate reduces the gastrointestinal absorption of norfloxacinAntimicrobial Agents and Chemotherapy, 1989